Feasibility of triweekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer.
N. Takaha
No relevant relationships to disclose
T. Iwata
No relevant relationships to disclose
T. Nakamura
No relevant relationships to disclose
F. Hongo
No relevant relationships to disclose
K. Kamoi
No relevant relationships to disclose
K. Okihara
No relevant relationships to disclose
A. Kawauchi
No relevant relationships to disclose
T. Miki
No relevant relationships to disclose